• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 HUMAN GROWTH HORMONE (IGF-I); RADIOIMMUNOASSAY, HUMAN GROWTH HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 HUMAN GROWTH HORMONE (IGF-I); RADIOIMMUNOASSAY, HUMAN GROWTH HORMONE Back to Search Results
Catalog Number 11128543
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/26/2024
Type of Reportable Event Malfunction
Event or Problem Description
The customer reported the observation of three erroneous falsely depressed patient results with insulin-like growth factor i (igf-i), lot number: 317 on an immulite® 2000 xpi immunoassay system, serial number: (b)(6).The falsely depressed patient results were reported to the physicians and were questioned.The samples were reprocessed on the other immulite 2000 xpi analyzer and one result was corrected sample: sample id (b)(6).There are no known reports of patient intervention or adverse health consequences due to the issue.
 
Additional Manufacturer Narrative
An outside the united states customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding the observation of three erroneous falsely depressed patient results with insulin-like growth factor i (igf-i) lot 317 on an instrument is an immulite® 2000 xpi immunoassay system.Quality control (qc) did not recover within range when samples were initially tested.The qc on the alternate instrument used for reprocessing the samples qc was in range.Siemens is currently investigating the issue.
 
Additional Manufacturer Narrative
Mdr 1219913-2024-00442 was filed on 24-october-2024.Additional information - 12-november-2024: siemens reviewed the information provided by the customer.There were no instrument interventions that occurred when the depressed results were observed.Repeat igf-1 testing of samples prior to the elevated results showed no issues.Review of quality control (qc) indicated failures (values which were low out of range) were observed during the same time period as the discrepant results.The customer replaced the reagents with new packs from the same lot and performed a new adjustment.Qc came in range.The customer is operational.The issue was resolved by routine troubleshooting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 HUMAN GROWTH HORMONE (IGF-I)
Common Device Name
RADIOIMMUNOASSAY, HUMAN GROWTH HORMONE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
llanberis, gwynedd LL55 4EL
UK  LL55 4EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED SIEMENS HEA
3002806944
glyn rhonwy LL55 4EL
UK   LL55 4EL
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key20508144
Report Number1219913-2024-00442
Device Sequence Number15433933
Product Code CFL
UDI-Device Identifier00630414601236
UDI-Public(01)00630414601236(10)317(17)241130
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2024
Device Catalogue Number11128543
Device Lot Number317
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/11/2024
Supplement Date Received by Manufacturer11/12/2024
Initial Report FDA Received Date10/22/2024
Supplement Report FDA Received Date11/22/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/13/2024
Is the Device Labeled for Single Use? (Y/N) No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-